Quality comparability assessment of a SARS-CoV-2-neutralizing antibody across transient, mini-pool-derived and single-clone CHO cells-Reference-Cited by-同舟云学术

Quality comparability assessment of a SARS-CoV-2-neutralizing antibody across transient, mini-pool-derived and single-clone CHO cells

Published:2021-12-20 Issue:1 Volume:14 Page:
ISSN:1942-0862
Container-title:mAbs
language:en
Short-container-title:mAbs

Author:

Xu Gangling¹,Yu Chuanfei¹,Wang Wenbo¹,Fu Cexiong²,Liu Hongchuan²,Zhu Yanping²,Li Yuan²,Liu Chunyu¹,Fu Zhihao¹,Wu Gang¹,Li Meng¹,Guo Sha¹,Yu Xiaojuan¹,Du Jialiang¹,Yang Yalan¹,Duan Maoqin¹,Cui Yongfei¹,Feng Hui²,Wang Lan¹

Affiliation:

1. Key Laboratory of the Ministry of Health for Research on Quality and Standardization of Biotech Products, China National Institutes for Food and Drug Control, Beijing, China

2. Shanghai Junshi Biosciences Co. Ltd, Shanghai, China

Funder

National Key R&D Program of China

Publisher

Informa UK Limited

Subject

Immunology,Immunology and Allergy

Link

https://www.tandfonline.com/doi/pdf/10.1080/19420862.2021.2005507

Reference20 articles.

1. Addendum: A pneumonia outbreak associated with a new coronavirus of probable bat origin

2. Remdesivir for the Treatment of Covid-19 — Final Report